S

Spruce Biosciences

33 employees

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Biopharma

Date founded

2016

Funding rounds raised

Total raised

$88M

from 15 investors over 15 rounds

S

Spruce Biosciences raised $54M on February 9, 2023

Investors: Armistice Capital LLC, RiverVest Venture Partners, Abingworth, 5AM Ventures, Novo Holdings and HealthCap

S

Spruce Biosciences raised $88M on February 20, 2020

Investors: Omega Funds, Aisling Capital, RiverVest Venture Partners, Surveyor Capital, Sands Capital Management, HealthCap, Abingworth and Novo Holdings

S

Spruce Biosciences raised $20M on January 2, 2016

Investors: RiverVest Venture Partners

FAQ